Healthcare Global Enterprises Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
HCG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Healthcare Global Enterprises (HCG) has informed the stock exchanges that the trading window for its shares will remain closed from July 1, 2025, until 48 hours after the company declares its financial results for the quarter ending June 30, 2025. This is a standard compliance measure under SEBI's Prohibition of Insider Trading Regulations, meaning designated employees and insiders cannot buy or sell HCG shares during this period. The closure signals that the company's Q1 FY2026 results announcement is expected soon. Investors should note that this is a routine regulatory filing and not a reflection of any negative event.
This is a routine compliance filing with no direct impact on the stock price. However, it does signal that Q1 FY2026 results are imminent, which could introduce near-term volatility based on the numbers reported.